We transform Australia & New Zealand's most exciting biomedical research discoveries into new medical products that improve patient outcomes and save lives.
Brandon BioCatalyst is the largest life science investment fund in Australia and New Zealand. We are a unique collaboration between major Australian superannuation funds, CSL, the Australian and New Zealand governments, Australian state governments and more than 50 leading medical research institutes and research hospitals.
We’re immensely proud of our portfolio. Partnering with talented scientists, clinicians and entrepreneurs, we have supported more than 50 companies to date.
Que Oncology
Que Oncology
A clinical stage company developing treatment for hot flashes in cancer survivors undergoing endocrine therapy
Brandon BioCatalyst brings together more than 50 leading medical research institutes across Australia and New Zealand.
Institute
QIMR Berghofer Medical Research Institute
QIMR Berghofer is one of Australia’s most successful medical research institutes. The Institute was established 70 years ago by the Queensland Government and has a rich history of scientific discoveries and translational medical research.
The Garvan Institute of Medical Research is one of Australia's premier medical research institutes. We see a future where everyone lives a longer, healthier life.
Brandon BioCatalyst is innovation in action: We provide a path for taking medical science from conception into the real world.
Our Venture capital model is unique. We don’t simply provide investment, we partner with entrepreneurs to create businesses, run companies and everything necessary to ensure our investments succeed.
